{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:36:12Z","timestamp":1774355772947,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.4158\/ep-2020-0023","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:28:37Z","timestamp":1596720517000},"page":"787-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Pathophysiologic Primary Prevention Review of Aspirin Administration to Prevent Cardiovascular Thrombosis"],"prefix":"10.1016","volume":"26","author":[{"given":"David S.","family":"Schade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Burchiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.Philip","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2020-0023_bb0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4158\/EP-2018-0073","article-title":"Aspirin for primary prevention in patients with type 2 diabetes","volume":"24","author":"Foster","year":"2018","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2020-0023_bb0015","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis; the Heinz Nixdorf Recall Study","volume":"56","author":"Erbel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2020-0023_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomized trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"10.4158\/EP-2020-0023_bb0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","article-title":"Role of aspirin in primary prevention of cardiovascular disease","volume":"16","author":"Patrono","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0035","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.4158\/EP-2020-0023_bb0040","unstructured":"MeyerJ, ArpsK, BlumenthalRS, MartinSS.(2018) New data on aspirin use in the era of more widespread statin use. American College of Cardiology. Available at: https:\/\/www.acc.org\/latest-incardiology\/articles\/2018\/09\/28\/08\/08\/new-data-on-aspirin-use-in-the-era-of-more-widespread-statin-use. Accessed May 19, 2020."},{"key":"10.4158\/EP-2020-0023_bb0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2020-0023_bb0050","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomized, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.4158\/EP-2020-0023_bb0055","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1001\/archinte.163.17.2006","article-title":"An update on aspirin in the primary prevention of cardiovascular disease","volume":"163","author":"Eidelman","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP-2020-0023_bb0060","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2012.5034","article-title":"Association of aspirin use with major bleeding in patients with and without diabetes","volume":"307","author":"Berardis","year":"2012","journal-title":"JAMA"},{"key":"10.4158\/EP-2020-0023_bb0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2011.04.006","article-title":"Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trails","volume":"162","author":"Berger","year":"2011","journal-title":"Am Heart J"},{"key":"10.4158\/EP-2020-0023_bb0070","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2019.03.501","article-title":"Aspirin for primary prevention of cardiovascular events","volume":"73","author":"Abdelaziz","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11318440-000000000-00000","article-title":"Low-dose aspirin therapy for cardiovascular prevention. Quantification and consequences of poor compliance or discontinuation","volume":"10","author":"Herlitz","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.4158\/EP-2020-0023_bb0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recommendation statement","volume":"150","author":"US Preventive Services Task Force.","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2020-0023_bb0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcmg.2013.01.003","article-title":"Coronary plaque erosion: recognition and management","volume":"6","author":"Braunwald","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.4158\/EP-2020-0023_bb0090","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.2019.8388","article-title":"A practical approach to low-dose aspirin for primary prevention","volume":"322","author":"Chiang","year":"2019","journal-title":"JAMA"},{"key":"10.4158\/EP-2020-0023_bb0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease","volume":"165","author":"Cook","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2020-0023_bb0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/M16-1110","article-title":"Cardiovascular risk assessment: a systematic review of guidelines","volume":"165","author":"Khanji","year":"2016","journal-title":"Ann Int Med"},{"key":"10.4158\/EP-2020-0023_bb0105","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.jacc.2016.02.055","article-title":"Accuracy of the atherosclerotic cardiovascular risk equation in a large contemporary, multiethnic real-world population","volume":"67","author":"Rana","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0110","first-page":"598","volume":"38","author":"DeFilippis","year":"2017","journal-title":"Eur Heart J"},{"key":"10.4158\/EP-2020-0023_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2005.04.004","article-title":"Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women","volume":"184","author":"Michos","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP-2020-0023_bb0120","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2020-0023_bb0125","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/ATVBAHA.116.308305","article-title":"Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease","volume":"36","author":"Varbo","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.4158\/EP-2020-0023_bb0130","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"key":"10.4158\/EP-2020-0023_bb0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacc.2015.10.058","article-title":"Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment","volume":"67","author":"Yeboah","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0140","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.89.5.2462","article-title":"A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"89","author":"Stary","year":"1994","journal-title":"Circulation"},{"key":"10.4158\/EP-2020-0023_bb0145","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2020-0023_bb0150","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","article-title":"Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology\/American Heart Association cholesterol management guidelines","volume":"66","author":"Nasir","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcct.2017.02.010","article-title":"Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of Cardiovascular Computed Tomography","volume":"11","author":"Hecht","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.4158\/EP-2020-0023_bb0160","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term anti-platelet treatment after vascular events: a population-based cohort study","volume":"390","author":"Li","year":"2017","journal-title":"Lancet"},{"key":"10.4158\/EP-2020-0023_bb0165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jcin.2010.05.001","article-title":"The effect of lipid and inflammatory profiles on the morphological changes of lipid rich plaques in patients with non-ST-segment elevated acute coronary syndrome","volume":"3","author":"Takarada","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.4158\/EP-2020-0023_bb0170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.amjcard.2006.12.026","article-title":"Presence and severity of noncalcified coronary plaque on 64-slice computed tomographic coronary angiography in patients with zero and low coronary artery calcium","volume":"99","author":"Cheng","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.4158\/EP-2020-0023_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/FJC.0b013e318165dcad","article-title":"Rapid stabilization of vulnerable carotid plaque within 1 month of pitavastatin treatment in patients with acute coronary syndrome","volume":"51","author":"Nakamura","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.4158\/EP-2020-0023_bb0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.4158\/EP-2020-0023_bb0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2261-14-60","article-title":"Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound","volume":"14","author":"Gao","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.4158\/EP-2020-0023_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4236\/wjcd.2019.97043","article-title":"The rationale for a different approach to preventing cardiovascular disease","volume":"9","author":"Schade","year":"2019","journal-title":"World J Cardiovasc Dis"},{"key":"10.4158\/EP-2020-0023_bb0200","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1210\/jc.2018-02509","article-title":"A simplified approach to reducing cardiovascular risk","volume":"104","author":"Schade","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2020-0023_bb0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0735-1097(01)01799-5","article-title":"Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound","volume":"39","author":"Jang","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0210","doi-asserted-by":"crossref","first-page":"021002","DOI":"10.1117\/1.2192697","article-title":"Optical coherence tomography for imaging the vulnerable plaque","volume":"11","author":"Tearney","year":"2006","journal-title":"J Biomed Opt"},{"key":"10.4158\/EP-2020-0023_bb0215","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.CIR.0000159354.43778.69","article-title":"In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography","volume":"111","author":"Jang","year":"2005","journal-title":"Circulation"},{"key":"10.4158\/EP-2020-0023_bb0220","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.amjcard.2005.11.035","article-title":"Assessment of coronary arterial plaque by optical coherence tomography","volume":"97","author":"Kume","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0225","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jacc.2007.04.082","article-title":"Assessment of culprit lesion morphology in acute myocardial infarction","volume":"50","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MCA.0b013e32830042a8","article-title":"Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study","volume":"19","author":"Chia","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.4158\/EP-2020-0023_bb0235","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.atherosclerosis.2008.05.014","article-title":"Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study","volume":"202","author":"Takarada","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.4158\/EP-2020-0023_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcmg.2011.11.012","article-title":"Impact of statin therapy of plaque characteristics as assessed by serial OCT grayscale and integrated backscatter-IVUS","volume":"5","author":"Hattori","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.4158\/EP-2020-0023_bb0245","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","article-title":"Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography","volume":"64","author":"Komukai","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.4158\/EP-2020-0023_bb0250","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.amjmed.2019.01.042","article-title":"Prescribing statins to reduce cardiovascular disease: 10 common misconceptions","volume":"132","author":"Schade","year":"2019","journal-title":"Am J Med"},{"key":"10.4158\/EP-2020-0023_bb0255","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2012.12.007","article-title":"OCT-based diagnosis and management of STEMI associated with intact fibrous cap","volume":"6","author":"Prati","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.4158\/EP-2020-0023_bb0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/CIRCOUTCOMES.113.000690","article-title":"The use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis","volume":"7","author":"Miedema","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.4158\/EP-2020-0023_bb0265","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1210\/js.2016-1080","article-title":"Management of asymptomatic patients with positive coronary artery calcium scans","volume":"1","author":"Burge","year":"2017","journal-title":"J Endo Soc"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:41Z","timestamp":1761516521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20360213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1530891X20360213"],"URL":"https:\/\/doi.org\/10.4158\/ep-2020-0023","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Pathophysiologic Primary Prevention Review of Aspirin Administration to Prevent Cardiovascular Thrombosis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2020-0023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}